Page last updated: 2024-10-31

w 12 and Psoriasis

w 12 has been researched along with Psoriasis in 1 studies

W 12: calmodulin antagonist; W13 analog with Cl deleted from benzene ring

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pinter, A1
Puig, L1
Schäkel, K1
Reich, A1
Zaheri, S1
Costanzo, A1
Tsai, TF1
Smith, SD1
Lynde, C1
Brnabic, A1
Reed, C1
Hill, J1
Schuster, C1
Riedl, E1
Paul, C1

Other Studies

1 other study available for w 12 and Psoriasis

ArticleYear
Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO).
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:11

    Topics: Adult; Arthritis, Psoriatic; Biological Products; Humans; Psoriasis; Severity of Illness Index; Sulf

2022